At 36 weeks, 31.7 percent of participants taking both medications met the studys two main goals at least a 50 percent improvement in PsA signs and symptoms (ACR50) and at least 10 percent weight loss
McGuire DK, Alexander JH, Johansen OE, Perkovic V, Rosenstock J, Cooper ME, Wanner C, Kahn SE, Toto RD, Zinman B, Baanstra D, Pfarr E, Schnaidt S, Meinicke T, George JT, von Eynatten M, Marx N, Cahn A
And critically, peptides do not bind to glass surfaces the way they bind to plastic
Pourkarim F, Pourtaghi-Anvarian S, Rezaee H
Although a considerable amount of research has been conducted on the pathogenesis, epidemiology, immunology, and prevention of hepatitis B, and preventive hepatitis B vaccines are widely used globally, many chronic hepatitis B patients and HBV carriers still cannot be cured